Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study

Natale Quartuccio,Laura Evangelista,Pierpaolo Alongi,Federico Caobelli,Corinna Altini,Angelina Cistaro,Alessandro Lambertini,Ilaria Schiorlin,Cristina E. Popescu,Flavia Linguanti,Riccardo Laudicella,Federica Scalorbi,Giulia Di Pierro,Artor Niccoli-Asabella,Lea Cuppari,Simone Margotti,Giacomo Maria Lima,Salvatore Scalisi,Sara Pacella,Aurora Kokomani,Alfonso Ciaccio,Letterio Sturiale,Antonio Vento,Davide Cardile,Sergio Baldari,Stefano Panareo,Stefano Fanti,Giuseppe Rubini,Orazio Schillaci,Agostino Chiaravalloti

Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study

2019

BackgroundThe presence of residual disease after initial treatment in small cell lung cancer (SCLC) influences prognosis and impacts patient management. To date, few data exist on the value of fluorine-18-fluorodeoxyglucose ([18F]FDG)-PET/computed tomography (CT) in SCLC at restaging. Therefore, in

Keywords:

Radiology
PET-CT
Small Cell Lung Carcinoma
Medicine
multicenter study
initial treatment
fdg pet ct
Computed tomography
patient management
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations